{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:13:40Z","timestamp":1790334820818,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.ad.2013.06.005","type":"journal-article","created":{"date-parts":[[2013,12,4]],"date-time":"2013-12-04T20:30:34Z","timestamp":1386189034000},"page":"813-821","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Psoriasis y embarazo: revisi\u00f3n (II)"],"prefix":"10.1016","volume":"105","author":[{"given":"V.","family":"Ruiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Manubens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Puig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2013.06.005_bib0005","first-page":"219","article-title":"Biologic therapy and pregnancy. A systematic literature review","volume":"36","author":"Bogas","year":"2011","journal-title":"Acta Reumatol Port"},{"key":"10.1016\/j.ad.2013.06.005_bib0010","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jaad.2011.07.039","article-title":"Review of treatment options for psoriasis in pregnant or lactating women: From the medical board of the National Psoriasis Foundation","volume":"67","author":"Bae","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2013.06.005_bib0015","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2174\/138920111795470903","article-title":"Transplacental transfer of immunosuppresants and biologics used for the treatment of inflammatory bowel disease","volume":"12","author":"Chaparro","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.ad.2013.06.005_bib0020","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1002\/art.22028","article-title":"British Society, for Rheumatology Biologics Register Pregnancy outcome in women who were exposed to anti-tumor necrosis factor agents: Results from a national population register","volume":"54","author":"Hyrich","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"Suppl","key":"10.1016\/j.ad.2013.06.005_bib0025","first-page":"S426","article-title":"Pregnancy outcomes in women taking infliximab: The infliximab safety database","volume":"58","author":"Snoeckx","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ad.2013.06.005_bib0030","unstructured":"Garc\u00eda J, Joven B, Ruiz T. Pregnancy in women receiving antiTNF therapy. Experience in Spain. Arthritis Rheum. 2005;52 Suppl:S349."},{"key":"10.1016\/j.ad.2013.06.005_bib0035","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1002\/art.22027","article-title":"Are we coming to terms with tumor necrosis factor inhibition in pregnancy?","volume":"54","author":"Salmon","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ad.2013.06.005_bib0040","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/ibd.21154","article-title":"Safety of immunomodulators and biologics for the treatment of inflammatory Bowel disease during pregnancy and breast-feeding","volume":"16","author":"Gisbert","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ad.2013.06.005_bib0045","first-page":"260","article-title":"Etanercept immunotherapy in women with a history of recurrent reproductive failure","volume":"83","author":"Jerzak","year":"2012","journal-title":"Ginekol Pol"},{"key":"10.1016\/j.ad.2013.06.005_bib0050","first-page":"2215","article-title":"Treatment of patients with rheumatoid arthritis who desire to become pregnant\u2014sucessful pregnancy in three cases treated with etanercept","volume":"66","author":"Murashima","year":"2008","journal-title":"Nihon Rinsho"},{"key":"10.1016\/j.ad.2013.06.005_bib0055","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4103\/0253-7613.45155","article-title":"Infertility improved by etanercept in ankylosing spondylitis","volume":"40","author":"Rezvani","year":"2008","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.ad.2013.06.005_bib0060","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pharmthera.2007.10.001","article-title":"Tumor necrosis factor antagonist mechanism of action: A comprehensive review","volume":"117","author":"Tracey","year":"2008","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ad.2013.06.005_bib0065","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.reprotox.2011.05.009","article-title":"Safety of infliximab use during pregnancy","volume":"32","author":"Djokanovic","year":"2011","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.ad.2013.06.005_bib0070","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1365-2036.2005.02405.x","article-title":"Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn\u2019 disease","volume":"21","author":"Mahadevan","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ad.2013.06.005_bib0075","doi-asserted-by":"crossref","unstructured":"Katz JA, Antoni C, Keenan GF, Smith DE, Jacobs SJ, Lichtenstein GR. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am J Gastroenterol. 2004;99:2385-2392.","DOI":"10.1111\/j.1572-0241.2004.30186.x"},{"key":"10.1016\/j.ad.2013.06.005_bib0080","first-page":"A54","article-title":"Safety of infliximab in Crohn\u2019 disease: Data from 5,000 patients TREAT registry","volume":"126","author":"Lichtenstein","year":"2004","journal-title":"Gastroenterol"},{"key":"10.1016\/j.ad.2013.06.005_bib0085","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3899\/jrheum.080545","article-title":"A safety assessment of tumor necrosis factor antagonists during pregnancy: A review of the Food and Drug Administration database","volume":"36","author":"Carter","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ad.2013.06.005_bib0090","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3899\/jrheum.081083","article-title":"Do tumor necrosis factor inhibitors cause malformations in humans","volume":"36","author":"Koren","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ad.2013.06.005_bib0095","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.3899\/jrheum.101316","article-title":"The distribution of congenital anomalies within the VACTERL association among tumor necrosis factor antagonist-exposed pregnancies is similar to the general population","volume":"38","author":"Crijns","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ad.2013.06.005_bib0100","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1002\/ibd.21583","article-title":"Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy","volume":"17","author":"Schnitzler","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ad.2013.06.005_bib0105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4321\/S1130-01082012000200003","article-title":"Is safety infliximb during pregnancy in patients with inflammatory bowel disease?","volume":"104","author":"Arg\u00fcelles-Arias","year":"2012","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.ad.2013.06.005_bib0110","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000262284","article-title":"Treatment of psoriasis with anti TNF drugs during pregnancy: Case report and review of the literature","volume":"220","author":"Puig","year":"2010","journal-title":"Dermatology"},{"key":"10.1016\/j.ad.2013.06.005_bib0115","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.cgh.2006.07.018","article-title":"Case report: Evidence for transplacental transfer of maternally administered infliximab to the newborn","volume":"4","author":"Vasiliauskas","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.ad.2013.06.005_bib0120","first-page":"A144","article-title":"Infliximab levels in infants born to women with inflammatory bowel disease","volume":"132","author":"Mahadevan","year":"2007","journal-title":"Gastroenterol."},{"key":"10.1016\/j.ad.2013.06.005_bib0125","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.crohns.2010.05.001","article-title":"Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn\u2019 disease","volume":"4","author":"Cheent","year":"2010","journal-title":"J Crohn\u2019 Colitis"},{"key":"10.1016\/j.ad.2013.06.005_bib0130","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/ajg.2010.464","article-title":"The London Position Statement of the World congress of Gastroenterology on biological therapy for IBD with the European Crohn\u2019 and Colitis organization: Pregnancy and pediatrics","volume":"106","author":"Mahadevan","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ad.2013.06.005_bib0135","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1358\/dot.2011.47.4.1576692","article-title":"Adalimumab for the treatment of immune-mediated diseases: An update an old and recent indications","volume":"47","author":"Murdaca","year":"2011","journal-title":"Drugs Today"},{"issue":"Suppl 10","key":"10.1016\/j.ad.2013.06.005_bib0140","first-page":"1874","article-title":"Pregnancy outcomes in women exposed to adalimumab: An update on the Autoimmune Diseases In Pregnancy Project","volume":"63","author":"Johnson","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ad.2013.06.005_bib0145","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1468-3083.2010.03756.x","article-title":"Pregnancy during adalimumab use for psoriasis","volume":"25","author":"Dessinioti","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2013.06.005_bib0150","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/ibd.21198","article-title":"Safety of adalimumab in Crohn\u2019 disease during pregnancy: Case report and review of the literature","volume":"16","author":"J\u00fcrgens","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ad.2013.06.005_bib0155","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1600-0897.2008.00669.x","article-title":"Treatment with adalimumab (Humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF","volume":"61","author":"Winger","year":"2009","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ad.2013.06.005_bib0160","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1600-0897.2011.00994.x","article-title":"Birth defect rates in women using adalimumab (Humira\u00ae) to treat immunologic-based infertility in IVF patients","volume":"66","author":"Winger","year":"2011","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ad.2013.06.005_bib0165","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3899\/jrheum.090563","article-title":"Can tumor necrosis factor inhibitors be safely used in pregnancy","volume":"37","author":"Ali","year":"2010","journal-title":"J Rheumatol"},{"issue":"Suppl 1","key":"10.1016\/j.ad.2013.06.005_bib0170","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0001-7310(10)70016-8","article-title":"Etanercept en el embarazo y lactancia","volume":"101","author":"Borrego","year":"2010","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2013.06.005_bib0175","first-page":"S682","article-title":"Pregnancy outcomes in women exposed to etanercept: The OTIS Autoimmune Diseases in Pregnancy Project","volume":"58","author":"Johnson","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ad.2013.06.005_bib0180","first-page":"S311","article-title":"Pregnancy outcome after exposure to biologics: Results from the german biologics register RABBIT","volume":"56","author":"Strangfeld","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ad.2013.06.005_bib0185","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/03009742.2011.626442","article-title":"Outcomes after anti-rheumatic drug use before and during pregnancy: A cohort study among 150,000 pregnant women and expectant fathers","volume":"41","author":"Viktil","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.ad.2013.06.005_bib0190","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/ard.2010.140822","article-title":"BSRBR Control Centre Consortium BSR Biologics Register Anti-TNF therapies and pregnancy: Outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register","volume":"70","author":"Verstappen","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ad.2013.06.005_bib0195","doi-asserted-by":"crossref","first-page":"491","DOI":"10.4321\/S1137-66272007000500016","article-title":"Etanercept y embarazo","volume":"30","author":"Otermin","year":"2007","journal-title":"An Sist Sanit Navar"},{"key":"10.1016\/j.ad.2013.06.005_bib0200","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jbspin.2008.04.016","article-title":"Exposition to antiTNF drugs during pregnancy: Outcome of 15 cases and review of the literature","volume":"76","author":"Berthelot","year":"2009","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.ad.2013.06.005_bib0205","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00393-010-0652-y","article-title":"Conception and course of eight pregnancies in five women on TNF blocker etanercept treatment","volume":"69","author":"Rump","year":"2010","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.ad.2013.06.005_bib0210","first-page":"241","article-title":"The use of disease modifying antirheumatic drugs women with rheumatoid arthritis of childbearing age. A survey of practice patterns and pregnancy outcome","volume":"30","author":"Chakravarty","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ad.2013.06.005_bib0215","first-page":"260","article-title":"Etanercept immunotherapy in women with a history of recurrent reproductive failure","volume":"83","author":"Jerzak","year":"2012","journal-title":"Ginekol Pol"},{"key":"10.1016\/j.ad.2013.06.005_bib0220","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1093\/rheumatology\/keq185","article-title":"Etanercept concentrations in maternal serum, umbilical cord serum, breast milk and child serum during breastfeeding","volume":"49","author":"Berthelsen","year":"2010","journal-title":"Rheumatol"},{"key":"10.1016\/j.ad.2013.06.005_bib0225","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/bdrb.20250","article-title":"Development in the Cynomolgus macaque following administration of ustekinumab, a human anti-IL-12\/23p40 monoclonal antibody, during pregnancy and lactation","volume":"89","author":"Martin","year":"2010","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"10.1016\/j.ad.2013.06.005_bib0230","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/MCG.0b013e31817f9367","article-title":"Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn\u2019 disease before and after delivery","volume":"43","author":"Kane","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.ad.2013.06.005_bib0235","first-page":"1017","article-title":"Etanercept in breast milk","volume":"31","author":"Ostensen","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ad.2013.06.005_bib0240","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1136\/ard.2008.105924","article-title":"Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: Drug levels in maternal serum, cord blood, breast milk and the infant's serum","volume":"68","author":"Murashima","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ad.2013.06.005_bib0245","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1093\/rheumatology\/keq185","article-title":"Etanercept concentrations in maternal serum, umbilical cord serum, breast milk and child serum during breastfeeding","volume":"49","author":"Berthelsen","year":"2010","journal-title":"Rheumatology (Oxford)"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731013003530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731013003530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:02:35Z","timestamp":1757552555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731013003530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0001731013003530"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2013.06.005","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psoriasis y embarazo: revisi\u00f3n (II)","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2013.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Espa\u00f1a, S.L.U. y AEDV. All rights reserved.","name":"copyright","label":"Copyright"}]}}